CAI · Caris Life Sciences, Inc.

$15.43 -0.22 (-1.41%)

Market Cap

$4.42B

282.68M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Dean Halbert	CEO	$764,918	$3,259,311	$15,400,569	—	—	$925,773	$20,350,571
David Spetzler	President	$611,934	$703,725	$2,780,988	$7,472,580	—	$14,000	$11,583,227
J. Russel Denton	General Counsel	$458,951	$263,897	$2,085,741	$2,532,025	—	$14,000	$5,354,614

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Dean Halbert	CEO	$750,000	$1,500,000	—	—	—	—	$2,250,000
David Spetzler	President	$600,000	$600,000	—	—	—	$13,800	$1,213,800

Key facts CIK 2019410 CUSIP 142152107 13F (30d) 29 filings 29 filers Visit website Investor relations